| |
| |
|
| Insider
Information: |
Simonian Nancy A |
| Relationship: |
|
| City: |
Woburn |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
135,658 |
|
|
Indirect Shares
|
164,975 |
|
|
| Direct
Value |
$724,414 |
|
|
|
Indirect Value
|
$854,400 |
|
|
| Total
Shares |
300,633 |
|
|
| Total
Value |
$1,578,814 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Millennium Pharmaceuticals Inc |
MLNM |
Chief Medical Officer |
2008-05-14 |
0 |
2008-05-01 |
4,975 |
Premium* |
|
|
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2013-05-17 |
0 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
|
2024-06-05 |
135,658 |
2016-07-06 |
160,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MLNM |
Millennium Pharmaceutical... |
Chief Medical OfficerOfficer |
• – – |
2007-05-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,424 |
|
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical OfficerOfficer |
• – – |
2007-05-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
69,012 |
|
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEOOfficer |
• • • |
2016-06-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
304,036 |
|
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEOOfficer |
• • • |
2016-06-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
160,000 |
|
- |
|
| MLNM |
Millennium Pharmaceutical... |
Chief Medical Officer |
• – – |
2008-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
30,940 |
97,776 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2013-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
3,500 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2014-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,500 |
7,000 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2015-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
10,700 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2016-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
14,400 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President and CEO |
• • – |
2016-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
66,666 |
370,702 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2017-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
18,100 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2018-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
21,800 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEO |
• • – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
188,000 |
669,288 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2019-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,963 |
24,763 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2020-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,335 |
26,098 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2021-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,402 |
27,500 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2022-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,503 |
54,003 |
0 |
- |
|
| SGEN |
Seagen Inc |
Director |
– • – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,044 |
64,797 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEO |
• • – |
2023-10-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,125 |
113,545 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
|
– • – |
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,566 |
145,710 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
|
– • – |
2024-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
135,658 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEO |
• • – |
2018-11-29 |
4 |
OE |
$1.01 |
$136,224 |
D/D |
110,588 |
481,288 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEO |
• • – |
2022-04-01 |
4 |
D |
$1.12 |
$65,949 |
D/D |
(58,883) |
692,723 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEO |
• • – |
2023-11-01 |
4 |
D |
$2.22 |
$29,750 |
D/D |
(13,401) |
100,144 |
0 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
President & CEO |
• • – |
2019-12-23 |
4 |
OE |
$3.04 |
$159,299 |
D/D |
52,401 |
533,689 |
0 |
- |
|
38 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
